Top

Quality of Life Research

Gepubliceerd in:

01-07-2015

Do health preferences contradict ordering of EQ-5D labels?

Auteurs: Benjamin M. Craig, A. Simon Pickard, Kim Rand-Hendriksen

Gepubliceerd in: Quality of Life Research | Uitgave 7/2015

Abstract

Purpose

The aim of this study was to test whether the ordering of item labels in EQ-5D instruments disagrees with the preferences of US adults.

Methods

A preference inversion occurs when “worse” health along a scale or score is preferred. As a sub-study of the 2013 United States Measurement and Valuation of Health Study, we tested for 33 EQ-5D preference inversions using paired comparisons with unique samples of 50 or more US adults, aged 18 or older. Specifically, we tested whether health preferences contradicted ordering of EQ-5D labels.

Results

The EQ-5D-3L and EQ-5D-Y item labels had no significant preference inversions. The EQ-5D-5L version had preference inversions between Levels 4 and 5. For example, 30 out of 59 respondents (51 %) preferred being “extremely” over “severely anxious or depressed,” contrary to the ordering of labels for that item.

Conclusions

Preference inversions between Levels 4 and 5 on the EQ-5D-5L were tested and confirmed; therefore, valuation studies may find that Levels 4 and 5 have the same value. To mitigate such inversions, labels could be revised or a 4-level version could be considered.

vorige artikel Mapping the disease-specific LupusQoL to the SF-6D

volgende artikel The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients

Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z. L., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef

Craig, B. M., Pickard, A. S., Stolk, E., & Brazier, J. E. (2013). US valuation of the SF-6D. Medical Decision Making, 33(6), 793–803.PubMedCentralPubMedCrossRef

Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of clinical epidemiology, 67(1), 93–99.

Craig, B. M., & Busschbach, J. J. V. (2011). Toward a more universal approach in health valuation. Health Economics, 20(7), 864–875.PubMedCrossRef

Xie, F., Pullenayegum, E., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., & Johnson, J. A. (2013). The Canadian EQ-5D-5L valuation study: An exploratory analysis, Table 1.4, 30th Scientific Plenary Meeting of the EuroQol Group. Montreal: EuroQol Group.

Craig, B., & Reeve, B. (2012). Patient-reported outcomes and preference research: Igniting the candle at both ends and the middle. ISPOR Connections Uniting Research and Practice, 18(5), 24.

Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and enhancing, the QALY. Value in Health, 12, S18–S26.PubMedCrossRef

Pickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., & Cella, D. (2007). Evaluating equivalency between response systems: Application of the Rasch model to a 3-level and 5-level EQ-5D. Medical Care, 45(9), 812–819.PubMedCrossRef

10.

The EuroQol Group. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef

11.

Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedCentralPubMedCrossRef

12.

Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.

13.

Ravens-Sieberer, U., Wille, N., Badia, X., Bonsel, G., Burstrom, K., Cavrini, G., et al. (2010). Feasibility, reliability, and validity of the EQ-5D-Y: Results from a multinational study. Quality of Life Research, 19(6), 887–897.PubMedCentralPubMedCrossRef

14.

Wille, N., Badia, X., Bonsel, G., Burstrom, K., Cavrini, G., Devlin, N., et al. (2010). Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research, 19(6), 875–886.PubMedCentralPubMedCrossRef

15.

Craig, B. M., Schell, M. J., Brown, P. M., Reeve, B. B., Cella, D., Hays, R. D., Lipscomb, J., Pickard, A. S., & Revicki, D. A. (2011). HRQoL values for cancer survivors: Enhancing PROMIS measures for CER (Vol. $3,978,708, p. 89). H. Lee Moffitt Cancer Center: NIH.

16.

Craig, B., & Reeve, B. (2012). Methods report on the PROMIS valuation study: Year 1. Moffitt Cancer Center. http://labpages.moffitt.org/craigb/Publications/Report120928.pdf.

17.

Craig, B. M., Pickard, A. S., & Lubetkin, E. I. (2014). Health problems are more common, but less severe when measured using newer EQ-5D versions. Journal of Clinical Epidemiology, 67(1), 93–99.PubMedCentralPubMedCrossRef

Titel: Do health preferences contradict ordering of EQ-5D labels?
Auteurs: Benjamin M. Craig
A. Simon Pickard
Kim Rand-Hendriksen
Publicatiedatum: 01-07-2015
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0897-z

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2015

Training clinicians in how to use patient-reported outcome measures in routine clinical practice

Role functioning is associated with survival in patients with hepatocellular carcinoma

Valuing EQ-5D health states for Sri Lanka

The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients

Health status and quality of life: results from a national survey in a community-dwelling sample of elderly people

Mapping the disease-specific LupusQoL to the SF-6D